Literature DB >> 6439358

Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".

P E Jennings, B P O'Malley, K E Griffin, B Northover, F D Rosenthal.   

Abstract

Fifteen patients receiving standard thyroxine replacement therapy (100-200 micrograms daily) for primary hypothyroidism and who had persistently raised free thyroxine concentrations in their serum were investigated to see whether the dose being given was too high. In addition to the usual thyroid hormone assays systolic time intervals (which indicate left ventricular contractility) were calculated as accurate reflectors of tissue thyroid activity. All patients showed the expected increased free and total thyroxine concentrations; but mean total and free concentrations of triiodothyronine were normal, while reverse triiodothyronine values were raised. Mean systolic time intervals were significantly reduced as compared with normal and fell within the thyrotoxic range. Seven patients subsequently had their doses of thyroxine reduced by 50 micrograms daily and were reinvestigated one month later. All showed significant falls in circulating thyroxine and triiodothyronine concentrations and an increase in mean systolic time intervals to the normal range. In patients receiving thyroxine replacement therapy for primary hypothyroidism a raised serum thyroxine concentration may indicate tissue thyrotoxicosis and should prompt a reduction of the thyroxine dose.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439358      PMCID: PMC1443837          DOI: 10.1136/bmj.289.6459.1645

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.

Authors:  M Maeda; N Kuzuya; Y Masuyama; Y Imai; H Ikeda
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

2.  Assessment of optimal L-thyroxine replacement dose by the TRH test.

Authors:  C R Squire; T M Gimlette
Journal:  Ann Clin Biochem       Date:  1982-01       Impact factor: 2.057

3.  Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.

Authors:  C J Pearce; R L Himsworth
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

4.  Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.

Authors:  E Soppi; K Irjala; H L Kaihola; J Viikari
Journal:  Scand J Clin Lab Invest       Date:  1984-06       Impact factor: 1.713

5.  Systolic time intervals in hypothyroidism: end organ function as a reflection of clinical status.

Authors:  G D Plotnick; D L Vassar; A F Parisi; B P Hamilton; N H Carliner; M L Fisher
Journal:  Am J Med Sci       Date:  1979 May-Jun       Impact factor: 2.378

6.  Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine.

Authors:  J C Ingbar; M Borges; S Iflah; R E Kleinmann; L E Braverman; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

7.  The relationship between levels of thyroid stimulating hormone and of thyroxine and triiodothyronine in blood of hypothyroid patients.

Authors:  K Johansen; J M Hansen; L Skovsted
Journal:  Acta Endocrinol (Copenh)       Date:  1978-08

8.  Alterations in systolic time intervals in primary hypothyroidism as a consequence of warming.

Authors:  B Northover; B P O'Malley; F D Rosenthal
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

9.  Gynecomastia in men following antineoplastic therapy.

Authors:  D L Trump; M D Pavy; S Staal
Journal:  Arch Intern Med       Date:  1982-03

10.  Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants.

Authors:  M J Maisels; A Pathak; N M Nelson; D G Nathan; C A Smith
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

  10 in total
  19 in total

1.  Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiter.

Authors:  J J Corrales; J M Tabernero; J M Miralles; M T Hernández
Journal:  Klin Wochenschr       Date:  1991-01-04

Review 2.  Bone and thyroid hormones.

Authors:  F Tremollieres; J M Pouilles; J P Louvet; C Ribot
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

Review 3.  Thyroxine replacement treatment and osteoporosis.

Authors:  J A Franklyn; M C Sheppard
Journal:  BMJ       Date:  1990-03-17

4.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

5.  Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement?

Authors:  W D Fraser; E M Biggart; D S O'Reilly; H W Gray; J H McKillop; J A Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

6.  A computer-assisted thyroid follow-up system.

Authors:  P D Davies; J H Lazarus; M H Wheeler
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

7.  Thyroxine replacement treatment: clinical judgment or biochemical control?

Authors:  A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

8.  Thyroxine replacement treatment.

Authors:  A W Goolden
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

9.  Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement.

Authors:  R J Mardell; T R Gamlen
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-05

10.  Male transient hip osteoporosis: are physicians at a higher risk?

Authors:  Azmy M Hadidy; Nosaiba T Al Ryalat; Shaher T Hadidi; Emad S Tarawneh; Maher T Hadidi; Osama A Samara; Deema M Abu-Labn; Lawrence M Al-Rousan; Dana A Hiyasat; Hanan A Hamamy
Journal:  Arch Osteoporos       Date:  2009-06-16       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.